Victor Neduva, Programme Lead, Merck Research Labs UK, Merck
Victor leads early discovery projects, and planning and implementation of genetics and genomic strategy at the London discovery centre. He has over 10 years of experience applying genomics and computational methodologies to large multi omics datasets for target discovery and validation, mechanistic biology, patient stratification and biomarkers discovery. Victor has experience in multiple therapeutic areas (e.g. Respiratory, Neuroscience and Rare diseases), spending 8 years at GSK, 3 years at the University of Edinburgh and also as co-founder and Scientific Officer of a spin-off company from the EMBL, NovaSterix. Victor has a PhD in Computational Biology from Heidelberg University.